Tonix Pharmaceuticals (TNXP) News Today $35.13 -0.31 (-0.87%) As of 02:27 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TNXP Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 2.5% - Here's WhyJuly 7 at 1:14 PM | marketbeat.comTonix Pharmaceuticals Announces Oral Presentation on Mpox and Smallpox vaccine candidate TNX-801 at the Vaccine Congress 2025July 7 at 7:00 AM | globenewswire.comTNXP Tonix Pharmaceuticals Holding Corp. - Seeking AlphaJuly 4, 2025 | seekingalpha.comTonix Pharmaceuticals Announces Peer-Reviewed Publication in Cancer Cell Journal Highlighting Positive Preclinical Data of mTNX-1700 in Gastric Cancer Animal ModelsJuly 2, 2025 | globenewswire.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 3.7% - Here's WhyJuly 1, 2025 | marketbeat.comTonix Pharmaceuticals announces inclusion in Russell 3000, Russell 2000 indexesJune 30, 2025 | msn.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 2.4% - Should You Buy?June 30, 2025 | marketbeat.comTonix Pharmaceuticals to be added to Russell 3000, Russell 2000 indexesJune 30, 2025 | seekingalpha.comTonix Pharmaceuticals Announces Inclusion in the Russell 3000® and Russell 2000® IndexesJune 30, 2025 | globenewswire.comTonix Pharmaceuticals Holding Corp. - TNXP | Barron'sJune 29, 2025 | barrons.comTNXP | Tonix Pharmaceuticals Holding Corp. Stock Overview (U.S.: Nasdaq) - Barron'sJune 27, 2025 | barrons.comTonix Pharmaceuticals Holding Corp News (TNXP) - Investing.comJune 27, 2025 | investing.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 2.4% - Here's WhyJune 27, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 1.7% - Still a Buy?June 26, 2025 | marketbeat.comTonix Pharmaceuticals Holding Corp TNXP Company Vitals - U.S. NewsJune 26, 2025 | money.usnews.comTNXP - Tonix Pharmaceuticals Holding Corp News - MorningstarJune 26, 2025 | morningstar.comMTonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 3.3% - Time to Sell?June 25, 2025 | marketbeat.comRhumbline Advisers Invests $244,000 in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)June 25, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 5% - What's Next?June 24, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 2.5% - Should You Sell?June 23, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 3% - What's Next?June 20, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 1.7% - Here's What HappenedJune 19, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 1.7% - Time to Sell?June 18, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading 9.9% Higher - Still a Buy?June 16, 2025 | marketbeat.comTonix Pharmaceuticals: Big Risk, Bigger Reward - Initiating With A BuyJune 16, 2025 | seekingalpha.comTonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on ...June 16, 2025 | gurufocus.comTonix Pharmaceuticals (TNXP) Highlights Fibromyalgia Treatment at EULAR 2025 | TNXP Stock NewsJune 16, 2025 | gurufocus.comTonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on ...June 16, 2025 | gurufocus.comTonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025June 16, 2025 | globenewswire.comTwo Sigma Investments LP Makes New $66,000 Investment in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)June 14, 2025 | marketbeat.comMillennium Management LLC Lowers Holdings in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)June 14, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 2.8% - Time to Sell?June 13, 2025 | marketbeat.comTonix Pharmaceuticals: Is The Recent Sell-Off A Buy Occasion?June 13, 2025 | seekingalpha.comTonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of DirectorsJune 13, 2025 | globenewswire.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 10.1% - Here's What HappenedJune 12, 2025 | marketbeat.comTonix Pharma Stock Plunges 20% Pre-market On Share Sale Announcement, But Retail’s Not PessimisticJune 12, 2025 | msn.comTonix Pharmaceuticals stock falls after announcing $225 million share offeringsJune 12, 2025 | investing.comTonix Pharmaceuticals (TNXP) Files To Raise $500 Million, Shares TumbleJune 12, 2025 | benzinga.comTonix Shares Fall After Entering Sales, Purchase AgreementsJune 12, 2025 | marketwatch.comTonix Pharmaceuticals files $500M mixed securities shelf, shares down 15%June 12, 2025 | seekingalpha.comTonix Pharma Signs Major Sales Agreements for FundingJune 11, 2025 | tipranks.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading 1.9% Higher - What's Next?June 11, 2025 | marketbeat.comTonix Pharmaceuticals Announces Presentation at the 2025 BIO International ConventionJune 10, 2025 | globenewswire.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 2.8% - Here's What HappenedJune 9, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Upgraded to "Hold" at Wall Street ZenJune 7, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 6.4% - Time to Buy?June 6, 2025 | marketbeat.comTonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025June 5, 2025 | globenewswire.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 2.8% - What's Next?June 4, 2025 | marketbeat.comNorthern Trust Corp Acquires New Shares in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)June 4, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 10.4% - Time to Buy?June 3, 2025 | marketbeat.com Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address TNXP Media Mentions By Week TNXP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TNXP News Sentiment▼-0.570.58▲Average Medical News Sentiment TNXP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TNXP Articles This Week▼55▲TNXP Articles Average Week Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ardelyx News Aurinia Pharmaceuticals News Collegium Pharmaceutical News Verve Therapeutics News BGM Group News Enliven Therapeutics News Niagen Bioscience News Praxis Precision Medicines News Cidara Therapeutics News Akebia Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TNXP) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.